Next Article in Journal
Hydroxypyridinone Chelators: From Iron Scavenging to Radiopharmaceuticals for PET Imaging with Gallium-68
Previous Article in Journal
Pnserpin: A Novel Serine Protease Inhibitor from Extremophile Pyrobaculum neutrophilum
Article Menu
Issue 1 (January) cover image

Export Article

Open AccessArticle
Int. J. Mol. Sci. 2017, 18(1), 115; doi:10.3390/ijms18010115

Transthyretin: A Transporter Protein Essential for Proliferation of Myoblast in the Myogenic Program

1
Department of Medical Biotechnology, Yeungnam University, Gyeongsan 38541, Korea
2
Technology Convergence R&D Group, Korea Institute of Industrial Technology, Yeongcheon 770-200, Korea
3
Department of New Drug Discovery and Development, Chungnam National University, Daejon 305-764, Korea
4
College of Veterinary Medicine, Konkuk University, Seoul 143-701, Korea
5
Department of Physiology, College of Medicine, Yeungnam University, 42415, Korea
Theses authors contributed equally to this work.
*
Author to whom correspondence should be addressed.
Academic Editor: Julian Borejdo
Received: 1 October 2016 / Revised: 22 December 2016 / Accepted: 3 January 2017 / Published: 8 January 2017
(This article belongs to the Section Biochemistry, Molecular and Cellular Biology)
View Full-Text   |   Download PDF [10236 KB, uploaded 9 January 2017]   |  

Abstract

Irregularities in the cellular uptake of thyroid hormones significantly affect muscle development and regeneration. Herein, we report indispensable role of transthyretin (TTR) in maintaining cellular thyroxine level. TTR was found to enhance recruitment of muscle satellite cells to the site of injury, thereby regulating muscle regeneration. Fluorescence-activated cell sorting (FACS) and immunofluorescence analysis of TTRwt (TTR wild type) and TTRkd (TTR knock-down) cells revealed that TTR controlled cell cycle progression by affecting the expression of Cyclin A2. Deiodinase 2 (D2) mediated increases in triiodothyronine levels were found to regulate the expression of myogenic marker, myogenin (MYOG). Moreover, use of a coumarin derivative (CD) revealed a significant reduction in cellular thyroxine, thereby indicating that TTR play a role in the transport of thyroxine. Taken together, these findings suggest that TTR mediated transport of thyroxine represents a survival mechanism necessary for the myogenic program. The results of this study will be highly useful to the strategic development of novel therapeutics to combat muscular dystrophies. View Full-Text
Keywords: myoblast; transthyretin; proliferation; differentiation myoblast; transthyretin; proliferation; differentiation
Figures

Figure 1

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. (CC BY 4.0).

Supplementary material

Scifeed alert for new publications

Never miss any articles matching your research from any publisher
  • Get alerts for new papers matching your research
  • Find out the new papers from selected authors
  • Updated daily for 49'000+ journals and 6000+ publishers
  • Define your Scifeed now

SciFeed Share & Cite This Article

MDPI and ACS Style

Lee, E.J.; Pokharel, S.; Jan, A.T.; Huh, S.; Galope, R.; Lim, J.H.; Lee, D.-M.; Choi, S.W.; Nahm, S.-S.; Kim, Y.-W.; Park, S.-Y.; Choi, I. Transthyretin: A Transporter Protein Essential for Proliferation of Myoblast in the Myogenic Program. Int. J. Mol. Sci. 2017, 18, 115.

Show more citation formats Show less citations formats

Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Int. J. Mol. Sci. EISSN 1422-0067 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top